Organizing Committee Members
Director, Careggi University Hospital, Italy
Niccolò Marchionni is the Director of the Cardiothoracovascular Department at Careggi University Hospital in Florence. Italian Society of Gerontology and Geriatric Medicine (President: 2009-2011); Italian Society of Internal Medicine (in the National Board of Professors of Internal Medicine:2010-2012); Italian Society of Arterial Hypertension: 2002-present; Italian Society of Geriatric Cardiology (President: 2012-present). In Editorial Boards of “Giornale di Gerontologia”; “Aging, Clinical and Experimental Research” (Associate Editor); Journals of Gerontology-Series A Biological Sciences and Medical Sciences" (Associate Editor: 2012-2014). Member of the "Geriatric Working Group" and of the "Geriatric Steering Committee" of "Agenzia Italiana del Farmaco: AIFA - Italian Drugs Agency", 2009-present. Member of the Geriatric Experts Group (GEG) of "European Medicines Agency (London), EMA" 2011-present (Chairperson of GEG).
He is the Co-author in 225 original articles in peer-review journals quoted by PubMed
Dr.Alnoor Abdulla, Cardiologist, was born in Tanzania, East Africa in 1951. Dr. Abdulla is Board Certified and has Fellowships in Internal Medicine, Cardiology Subspecialty, Chest Medicine and Interventional Cardiology both in Canada and the U.S. (RCPSC & ABIM). He has practiced cardiology for over 3 decades and has been licensed in British Columbia, Ontario, Alberta, Washington State, California, Wisconsin and Pakistan. Dr Abdulla has been on several Boards as an Executive Member and Chairman. His experience is quite diverse with a variety of medical practice experiences, training in several areas and teaching Internationally
M Reza Movahed
Director , USA
Dr. Mohammad Reza Movahed received his MD from Medizinische Hochschule Hannover, Germany. He completed his medical residency at the University of Rochester, New York and his cardiology training at the University of South Caroline, Columbia. His final training in interventional cardiology was completed at Yale University Hospital, New Haven, Connecticut in 2000. After his training, he joined University of California Irvine as Assistant Clinical Professor and later joined University of Arizona College of Medicine in 2006 as Associate Professor of Medicine, Division of Cardiology. In July 2010, Dr. Movahed was promoted to Professor of Medicine, Tenure at the University of Arizona College of Medicine due to his excellent clinical work, teaching, service and research with over 200 peer reviewed publications. He has been Director of Cardiac Catheterization Laboratory and Nuclear Cardiology at the University of California, Irvine medical Center and Director of Coronary Care Unit and Medical Director of Cardiac Transplantation at the University of Arizona Medical Center. In 2007, he joined the Southern Arizona VA Health Care System for his clinical work and as the Medical Director of Heart Transplantation. In May 2012, he joined CareMore as The Regional Cardiology Director of CareMore in Arizona while keeping his teaching and research affiliation with the VA and the University of Arizona as Professor of Medicine, tenure. His major area of research is related to coronary intervention, non-invasive cardiology and cardiovascular epidemiology. He is world-renowned for his coronary bifurcation classification known as “The Movahed Classification” He is also known for his discovery on the flattening of interventricular septum as a sign for right ventricular overload the so called “ Movahed’s sign” that can be seen during Gated SPECT studied and recently published reverse “Movahed Maneuver” that can be used for improvement of stent deliverability during difficult and tortuous vein graft interventions.
Cardiac Surgeon, Italy
Marco Picichè (MD, Ph.D.) graduated with a degree in medicine from the University of Florence in 1995 and completed his cardiac surgery residency at the Tor Vergata University of Rome in 2000, both summa cum laude. He held regular teaching appointments at the university of Montpellier school of medicine, obtained certification by the French Board in cardiac surgery (Paris, 2007), earned his research master in surgical science (Paris, 2007), and received a university diploma in vascular surgery (Paris, 2007). In Canada he authored a research project on the occlusion of the internal mammary arteries as an alternative method of myocardial blood supply (2008, Laval University). In May 2009 he had the honor of opening the 44th Congress of the European Society for Surgical Research with a lecture on ‘‘The history of surgical research.’’ In September 2011 he received a doctor of philosophy (Ph.D.) in therapeutic innovations from Paris-Sud University. He is the Editor in Chief of the book: « Dawn and evolution of cardiac procedures: research avenues in cardiac surgery and interventional cardiology » (Springer-Verlag publishing house, September 2012). He patented a new surgical instrument. Currently he is a cardiac surgeon at San Bortolo Hospital in Italy.
Professor & Pediatric Cardiologist, Turkey
Zeliha Selamoglu is a Professor in Medical Biology department of Nigde Ömer Halisdemir University, Turkey. She earned her PhD in Biology from Inonu University, She has published over 110 peerreviewed journal articles with over 1150 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine: Associate Membership and European association for cancer research. She has served as Editorial Board member for many Journals.
Research Interest: Medical Biology, Molecular Biology, Biochemistry, Biotechnology, Oxidative stress, Antioxidants, Cancer.
Ahmed N Ghanem
Retired Consultant Urologist, Egypt
Dr Ghanem was educated in Egypt and qualified in 1968, Mansoura University, Egypt. He gained postgraduate experience in UK where he was promoted in posts up to the consultant level. He practiced as consultant Urologist in UK, Saudi Arabia and Egypt. During his career he reported over 60 articles. He discovered two new types of vascular shocks, proved that one physiological law is wrong and provided an alternative. He resolved the puzzles of 3 clinical syndromes; TURP syndrome, the LPHS and ARDS. He is now on an editorial board member of many journals while he is happily retired in Egypt
Zied Ibn El hadj
Head of Cardiology department, Tunisia
Miguel Alejandro Farah.
Director , San Bernardo Hospital, Argentina
Miguel Alejandro Farah has completed his PhD at the age of 23 years from Universidad Nacional de Córdoba and postdoctoral studies from Colegio Argentino de Cardioangiología Intervencionista-Universidad Nacional de Buenos Aires. He is the director of Interventional Cardiology Department at San Bernardo Hospital. His main interested topic is the treatment of acute myocardial infarction and reperfusion injury.
Miguel G. Garber
President in Spanish Society of Regenerative Medicine and Cell Therapy, Madrid Area, Spain
Dr. MIGUEL G. GARBER Dr. Garber has over 32 years of experience in Internal Medicine and Cardiology, in addition to training, research, and development expertise in Regenerative Medicine. Over the past 18 years, he has made a significant contribution to stem cell research, specializing in the exploration and development of stem cell therapies for cardiac disorders, osteoarthritis, neurological and autoimmune diseases. Formerly the Director of American Medical Information Group, he now serves as the Medical Director of Regenerative Medicine Madrid, Medical Director of hyperbaric Medicine unit in the La zarzuela Hospital and the President of the Spanish Society of Regenerative Medicine and Cell Therapy (SEMERETEC). He also proffessor a Master’s degree program in Regenerative Medicine and edits a number of scholarly journals on the subject.
Founder and Director, Heart Fit Clinic, Calgary, Alberta, Canada
Diamond possess 15 + years of experience in the healthcare industry. He has been featured extensively in the media as your trusted authority on heart disease rehabilitation and prevention and is also dynamic speaker educating his audiences on various topics on heart health and chronic disease management.
Diamond Fernandes is a clinical physiologist focusing on Cardiac Rehabilitation, Maintenance and Heart Attack and Stroke Prevention. Look out for his new book called "Beating Heart Disease". He has brought External ounterpulsation Therapy, also known as EECP and ECP to his cardiac rehabilitation patients and has seen amazing outcomes to prevent and reverse heart disease. Diamond, also focuses on Corporate Heart Health wellness programs to eliminate heart & chronic disease in the workplace. Delivers presentation to other healthcare professionals.
As the director, of a private cardiac wellness program, he is responsible for business development through marketing and sales. He has established clinic systems which include operational, networking, corporate vision, and execution. He has an extensive background in business training, franchising/licensing (healthcare) and internet marketing promoting heart health.
Specialties: Cardiac rehabilitation programming; External Counterpulsation Therapy, ECP, EECP; CVD treatment; Chronic disease management; Heart disease treatment; heart attack rehabilitation; corporate wellness programs; cardiac rehabilitation; hypertension; cholesterol; diabetes;overweight; family history; physical inactivity; strokes; blood clots; DVT; arrhythmia;heart failure; cardiomyopathy; atrial fibrillation
Associate Professor, National Heart Hospital
Currently Associate Professor of Cardiology at National Heart Hospital, Sofia
Eduardo W. Jørgensen
CEO & Co-founder at medicsen, Madrid, Spain
Eduardo W. Jørgensen is a Medical doctor with passion for neuroscience and Serial entrepreneur in med-tech and healthcare. CEO & Co-founder at medicsen which is a non invasive artificial pancreas for diabetes.
He has been executive officer for different projects (from medical school to my own ideas) and thus, have formed and guided teams to solve complex tasks through lean startup and scientific R&D. With MedicSen (team of 20) he have raised funds in three different rounds, successfully completed 3 individual R&D projects (algorithm to predict glucose, user interface to increase adherence and non invasive drug delivery system), filed a patent and negotiated with pharma and tech companies in different countries.
His goal is to help shape the use of technology in medicine in order to increase quality of life, and to keep looking forward for new opportunities to keep learning and improving in business, technology, science and innovation.
Awarded as Spanish innovator of the year 2017 by MIT technology review, Forbes 30 under 30 2018